Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: A randomised trial

Additional Metadata
Persistent URL	doi.org/10.1016/S0140-6736(05)17701-0, hdl.handle.net/1765/57706
Journal	The Lancet
Organisation	Department of Pathology
Citation APA APA Style APA-ALL Style AAA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Janssen, H., van Zonneveld, M., Senturk, H., Zeuzem, S., Akarca, U., Cakaloglu, Y., Simon, C., So, T., Gerken, G., de Man, R., Niesters, B., Zondervan, P., Hansen, B.& Schalm, S. (2005). Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: A randomised trial. The Lancet, 365(9454), 123–129.https://doi.org/10.1016/S0140-6736(05)17701-0

Publication